Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $15.3500 (3.82%) ($15.3500 - $15.3850) on Thu. Sep. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.7% (three month average) | RSI | 30 | Latest Price | $15.3500(3.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(60%) IWC(57%) IWO(54%) IWM(53%) IBUY(51%) | Factors Impacting EDIT price | EDIT will decline at least -2.85% in a week (0% probabilities). VIXM(-19%) UUP(-15%) VXX(-9%) TBT(-9%) EDOC(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.85% (StdDev 5.7%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.64(-123.71%) | Resistance Level | $16.49 | 5 Day Moving Average | $14.99(2.4%) | 10 Day Moving Average | $15.19(1.05%) | 20 Day Moving Average | $16.49(-6.91%) | To recent high | -20.5% | To recent low | 54.5% | Market Cap | $953m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |